Impact of Muscle Training Device on Non-Severe OSA
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThammasat University Hospital
About this trial
The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is:
• Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed.
Participants will:
* Use DidgeriTU or sham device for 3 month * Do an online questionnaire once a month during the study * Home sleep test, lung function test, and tongue strength test at the start and end of the study
Eligibility criteria
Qualifiers
Patients diagnosed with mild to moderate obstructive sleep apnea.
Age 18 years or older.
Patients voluntarily consent to provide information for research purposes.
Disqualifiers
Patients with an average apnea-hypopnea index (AHI) of <4 or >29 events per hour after repeated diagnosis using a home sleep apnea test.
Patients who refused to cease using CPAP during the study process
Patients with a history of chronic lung disease.
Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders.
Trial design
Treatments tested in this trial
- DidgeriTU
- Sham device
Treatment groups
76 Participants
are divided into 2 treatment groupsSponsors and collaborators
Thammasat University Hospital
Lead sponsor
Thammasat University
Sponsor institution
Source ClinicalTrials.gov